PMID: 42861Nov 17, 1979

Pindolol in the treatment of arrhythmias caused by exertion

Minerva medica
A GiordanoP Rossi

Abstract

In this study the anti-arrhythmic effectiveness of pindolol has been tested on ventricular effort arrhythmias in a group of 22 cardiopathic patients. The drug, administered for a week at the dose of 5 mg three times a day, obtained positive results due to its beta-blocking action and its intrinsic sympathomimetic activity.

Related Concepts

Visken
Exertion
Anti-Arrhythmia Agents
Antiarrhythmic [EPC]
Etiology
Pindolol
Heart Ventricle
Cardiac Arrhythmia
Increased Sympathetic Activity [PE]
Adrenergic beta-Antagonists

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.